#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune myositis Rhabdoid tumour Sjogren's syndrome Staphylococcal infection Transitional cell carcinoma Myotonic dystrophy Malignant melanoma Neonatal alloimmune thrombocytopenia Thalassaemia beta Chorioretinitis Renal cancer metastatic Demyelination Rosai-Dorfman syndrome Behcet's syndrome Retinal dystrophy More trials…

    Learn about Rare Diseases

    Nephroblastoma – Life with Disease IgA nephropathy – Trials in Disease Von Willebrand’s disease – Life with Disease Rett syndrome – Treatment Vascular malformation – Trials in Disease Waldenstrom’s macroglobulinaemia – Life with Disease Undifferentiated sarcoma – Diagnostics Retinitis pigmentosa – Life with Disease Nephrotic syndrome – Diagnostics Angiosarcoma non-metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Potassium Canrenoate 7-Ethyl-10-Hydroxycamptothecin Levodopa Prednisolone Acetate ZILUCOPLAN Tovorafenib Cevostamab Izorlisib Mesilate Insulin Human Levothyroxine INSULIN DEGLUDEC JNJ-75276617 Melphalan Flufenamide Trehalose Dihydrate (Ph.eur.) Vx-264 Atenolol Leucine Amg 193 Nimorazole Timbetasin Acetate More therapies…

    Learn about Your Condition

    Cognitive disorder Plasma cell leukaemia Systemic candida Urethral valves Alcohol abuse Metastases to rectum Pneumococcal infection Choroidal dystrophy Lupus nephritis Neoplasm Uterine cancer Shock Urethral stenosis HIV infection Chronic hepatitis C More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Effectiveness of REGV131 and LNP1265 for Adults with Hemophilia B

    Recruiting

    2 1 1
    Investigated Drugs:
    • Adeno-Associated Virus Vector Serotype 8 Containing The Human F9 Gene
    • Messenger Rna Encoding Cas9
    • Single Guide Rna Containing A Sequence Complementary To Human Alb Locus Gene, Intron 1, Target Region
    France Germany Italy Spain

  • Study on Hyperbaric Oxygen Therapy for Acute Hamstring Injury in Athletes and Military Personnel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle injury
    • Muscle strain
    • Tendon injury
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on Mifepristone for Patients with Treatment-Resistant Post-Traumatic Stress Disorder (PTSD)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Mifepristone
    • Placebo
    The Netherlands

  • Study on AVB-101 for Patients with Frontotemporal Dementia with Progranulin Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • Avb-101
    Belgium Italy The Netherlands Poland Spain Sweden

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Study on Everolimus and Lutetium (177Lu) Oxodotreotide for Treating Grades 2 and 3 Refractory Meningioma in Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Everolimus
    France
Previous Page
1 … 471 472 473 474 475 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!